conivaptan has been researched along with estrone in 1 studies
Studies (conivaptan) | Trials (conivaptan) | Recent Studies (post-2010) (conivaptan) | Studies (estrone) | Trials (estrone) | Recent Studies (post-2010) (estrone) |
---|---|---|---|---|---|
188 | 17 | 64 | 10,266 | 432 | 1,372 |
Protein | Taxonomy | conivaptan (IC50) | estrone (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.1261 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 6.589 | |
17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | 0.4134 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 5.301 | |
Estrogen receptor beta | Homo sapiens (human) | 0.3743 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for conivaptan and estrone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |